Chinese First-In-Class Endeavors See Triumphs, Setbacks In Early 2025

 
• By Dexter Jie Yan
  
Early 2025 recorded two successes and two setbacks for Chinese first-moving drugs and candidates. (Shutterstock)

More from China

More from Focus On Asia